EBV Re-Activation in CIS/MS Patients Relates to a Specific IgM+ MBC Phenotype but Was Not Associated With BAFF-R Expression or Abundance of IgA+ MBC. The gene discussed is CD79A; the disease is myeloid sarcoma.